Semi-Annual Consolidated Statement Of Cash Flows

Fuso Pharmaceutical Industries,Ltd. - Filing #7299997

Concept 2024-04-01 to
2024-09-30
As at
2024-09-30
As at
2024-03-31
2023-04-01 to
2023-09-30
As at
2023-09-30
As at
2023-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
934,000,000 JPY
12,000,000 JPY
Interest and dividends received
53,000,000 JPY
52,000,000 JPY
Interest paid
-55,000,000 JPY
-88,000,000 JPY
Income taxes paid
-162,000,000 JPY
-318,000,000 JPY
Net cash provided by (used in) operating activities
769,000,000 JPY
-341,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,391,000,000 JPY
-1,390,000,000 JPY
Proceeds from sale of investment securities
JPY
84,000,000 JPY
Other, net
-62,000,000 JPY
3,000,000 JPY
Net cash provided by (used in) investing activities
-1,749,000,000 JPY
-1,422,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
1,300,000,000 JPY
3,350,000,000 JPY
Repayments of long-term borrowings
-7,868,000,000 JPY
-1,876,000,000 JPY
Purchase of treasury shares
-2,000,000 JPY
-650,000,000 JPY
Dividends paid
-298,000,000 JPY
-349,000,000 JPY
Net cash provided by (used in) financing activities
477,000,000 JPY
1,272,000,000 JPY
Other, net
-1,000,000 JPY
JPY
Net increase (decrease) in cash and cash equivalents
-502,000,000 JPY
-492,000,000 JPY
Cash and cash equivalents
4,617,000,000 JPY
5,120,000,000 JPY
7,522,000,000 JPY
8,014,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.